HOME >> BIOLOGY >> NEWS
Acorda therapeutics receives NIH Phase 2 grant for central nervous system repair

t and repair the brain and spinal cord from injury," says Moses Rodriguez, M.D., Professor of Neurology and Immunology at Mayo Medical School.

Acorda Therapeutics, a privately held biotechnology company, is developing therapies for spinal cord injury (SCI) and related neurological conditions, including multiple sclerosis (MS). The Company's lead product, Fampridine-SR, is in Phase 3 clinical trials for chronic SCI and Phase 2 for MS. Acorda's technology platform includes two remyelinating agents in preclinical development for MS. The first is M1, a class of human monoclonal antibodies, and the second is GGF2, a product of the neuregulin 1 gene. Both agents have been shown to restore myelin in the brain and spinal cord in animal models of MS. Additionally, Acorda is developing protein- and stem cell-based technologies for regeneration and repair of the spinal cord and brain. In 2002, Acorda was the recipient of the National Spinal Cord Injury Association's L. W. Freeman Award for scientific research.


'"/>

Contact: Tierney Saccavino, Acorda Therapeutics
tsaccavino@acorda.com
914-347-4300
Porter Novelli
20-Dec-2002


Page: 1 2

Related biology news :

1. Acorda Therapeutics acquires CeNeS neuregulin products
2. Acorda Therapeutics receives L.W. Freeman Award for Scientific Research
3. Acorda Therapeutics begins Phase 3 trials of Fampridine-SR for chronic spinal cord injury
4. The future of HIV therapeutics is brightening, according to Gladstone Institutes Director
5. Molecular therapeutics advance fight against brain cancer
6. Conflicting views on embryonic and adult stem cells complicate research in stem cell therapeutics
7. Critical therapeutics is awarded U.S. patents for methods to diagnose and treat inflammatory disease
8. Immerge biotherapeutics identifies miniature swine that do not transmit pig retrovirus to humans
9. Polymer gel holds promise for therapeutics delivery and tissue engineering
10. Human Genome Sciences and Abgenix enter a broad collaboration to create fully human antibody therapeutics
11. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/27/2019)... ... , ... Since 2010, The HOTH has served over 200,000 businesses with awesome ... clients, they’ve earned a place on the highly-competitive and desirable Inc. 5,000 List of ... and accolades along the way. , Now, The HOTH is ready to ...
(Date:10/26/2019)... SAN FRANCISCO (PRWEB) , ... October 23, 2019 ... ... Chief Operating Officer, Christina Hughes , to its executive leadership team. , ... Medrio’s integrated technology solutions allow growth-stage biotech and pharma companies to reduce timelines ...
(Date:10/26/2019)... ... 24, 2019 , ... World Cord Blood Day (WCBD) takes place on November ... learn about the current and future uses of cord blood stem cells, and the ... to treat and cure over 80 different life-threatening diseases, including leukemia, lymphoma, and sickle ...
Breaking Biology News(10 mins):
(Date:11/2/2019)... (PRWEB) , ... October 31, 2019 , ... ... Adaptive Biotechnologies in a live webinar on Friday, November ... in immuno-oncology. , Immunosequencing, the science of profiling T-cell receptors (TCRs) and ...
(Date:10/29/2019)... ... 2019 , ... Modality Solutions, a biopharmaceutical cold ... validation workshop at the Biomanufacturing World Summit (BMWS19) Conference, November 11-12, 2019, at ... Biomanufacturing World Summit brings together pharmaceutical executives, cutting-edge technology providers, and media ...
(Date:10/22/2019)... ... 22, 2019 , ... Enplug , a leading cloud-based ... into its digital signage platform. The collaboration brings one of the most trusted ... to leverage their existing digital signage networks to quickly disseminate critical safety information ...
(Date:10/10/2019)... ... October 09, 2019 , ... The ... Deputy Commissioner, FDA, as a newly-confirmed keynote speaker for the 2019 ISPE ... Nevada USA. , Dr. Abernethy, a hematologist/oncologist and palliative medicine physician, is an ...
Breaking Biology Technology:
Cached News: